ANEB
Anebulo Pharmaceuticals, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Anebulo Pharmaceuticals (ANEB) Stock: Buy, Sell, or Hold?
$0.36
-0.07 (-16.49%)
▼
5d:
-23.89%
30d:
-57.89%
90d:
-84.79%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (76%)
Quality Score
44/100
Position
FAIR
Forward P/E & Valuation
-0.8x
Next 12M consensus est.
Wall Street Target
$3.00
+733.3% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.35 / $0.54
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ANEB is down 23.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ANEB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ANEB is currently trading at $0.36, which is considered fair based on recent price action.
Technical Outlook: Technically, ANEB is in a strong downtrend. The price is currently testing key support at $0.35. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 16.5% recently.
Market Sentiment: ANEB scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $3.00 (+733.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ANEB is in a strong downtrend. The price is currently testing key support at $0.35. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 16.5% recently.
Market Sentiment: ANEB scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $3.00 (+733.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
44/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
76.3%
Trading Range & Key Levels
Support Level
$0.35
Resistance Level
$0.54
Current Trend
Strong Downtrend
Technical data as of
Feb 27, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-16.5%)
- BULLISH: Trading 733.3% below Wall St target ($3.00)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.78
Wall Street Target
$3.00
(+733.3%)
Share ANEB Analysis
Share this live ANEB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ANEB)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Feb 18, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment prevails on $ANEB with no new news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 6:32 AM ET
Data refreshes hourly during market hours. Next update: 7:32 AM
Data refreshes hourly during market hours. Next update: 7:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANEB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 55 HOLD |
|
RZLT
Rezolute Inc |
STRONG BUY
11 analysts |
$10 | 72 BUY |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ANEB Research Pages
